Obesity and the gut microbiome: Striving for causality

Molecular Metabolism

Volumn 1, Issue 1-2, 2012, Pages 21-31

  Harley, Isaac T W ^a   Karp, Christopher L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Innate immunity; Microbiome; Microbiota; Non alcoholic fatty liver disease; Obesity; Segmented filamentous bacteria; Type 2 diabetes

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN A; INTERLEUKIN 17; LEPTIN; LEPTIN RECEPTOR; PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL LOAD; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTEROIDES THETAIOTAOMICRON; CD4+ T LYMPHOCYTE; COMMENSAL; DIET THERAPY; ENERGY TRANSFER; FECES; FIRMICUTES; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERMFREE ANIMAL; HUMAN; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; INTESTINE FLORA; METHANOBREVIBACTER SMITHII; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; MOLECULAR MECHANICS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SHORT SURVEY; WEIGHT GAIN; WEIGHT REDUCTION;

CANDIDATUS ARTHROMITUS SP. SFB-MOUSE;

EID: 84871891872     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2012.07.002     Document Type: Short Survey

References (139)

1. Abu-Shanab A., Quigley E.M. The role of the gut microbiota in nonalcoholic fatty liver disease. Nature Reviews Gastroenterology and Hepatology 2010, 7:691-701.
2. Adams T.D., Gress R.E., Smith S.C., Halverson R.C., Simper S.C., Rosamond W.D., et al. Long-term mortality after gastric bypass surgery. New England Journal of Medicine 2007, 357:753-761.
3. Ajslev T.A., Andersen C.S., Gamborg M., Sorensen T.I., Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. International Journal of Obesity (London) 2011, 35:522-529.
4. Angelakis E., Raoult D. The increase of Lactobacillus species in the gut flora of newborn broiler chicks and ducks is associated with weight gain. PLoS One 2010, 5:e10463.
5. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
6. Atkinson R.L., Dhurandhar N.V., Allison D.B., Bowen R.L., Israel B.A., Albu J.B., et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. International Journal of Obesity (London) 2005, 29:281-286.
7. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15718-15723.
8. Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:979-984.
9. Benson A.K., Kelly S.A., Legge R., Ma F., Low S.J., Kim J., et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:18933-18938.
10. Borody T.J., Khoruts A. Fecal microbiota transplantation and emerging applications. Nature Reviews Gastroenterology and Hepatology 2012, 9:88-96.
11. Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., Daniels D., et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. Journal of Biological Chemistry 2003, 278:11312-11319.
12. Cadwell K., Liu J.Y., Brown S.L., Miyoshi H., Loh J., Lennerz J.K., et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008, 456:259-263.
13. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine 2003, 348:1625-1638.
14. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
15. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
16. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
17. Caricilli A.M., Picardi P.K., de Abreu L.L., Ueno M., Prada P.O., Ropelle E.R., et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biology 2011, 9:e1001212.
18. Carter J.K., Ow C.L., Smith R.E. Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity. Infection and Immunity 1983, 39:410-422.
19. Cerf-Bensussan N., Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes?. Nature Reviews Immunology 2010, 10:735-744.
20. Christakis N.A., Fowler J.H. The spread of obesity in a large social network over 32 years. New England Journal of Medicine 2007, 357:370-379.
21. Claesson M.J., Cusack S., O'Sullivan O., Greene-Diniz R., de Weerd H., Flannery E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(1):4586-4591.
22. Clemente J.C., Ursell L.K., Parfrey L.W., Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012, 148:1258-1270.
23. Cohen P., Zhao C., Cai X., Montez J.M., Rohani S.C., Feinstein P., et al. Selective deletion of leptin receptor in neurons leads to obesity. Journal of Clinical Investigation 2001, 108:1113-1121.
24. Collado M.C., Isolauri E., Laitinen K., Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. American Journal of Clinical Nutrition 2008, 88:894-899.
25. Curtiss L.K., Tobias P.S. Emerging role of Toll-like receptors in atherosclerosis. Journal of Lipid Research 2009, 50(Suppl.):S340-S345.
26. Dale C., Moran N.A. Molecular interactions between bacterial symbionts and their hosts. Cell 2006, 126:453-465.
27. Dethlefsen L., Huse S., Sogin M.L., Relman D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biology 2008, 6:e280.
28. Dethlefsen L., Relman D.A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(1):4554-4561.
29. Donohoe D.R., Garge N., Zhang X., Sun W., O'Connell T.M., Bunger M.K., et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metabolism 2011, 13:517-526.
30. Dubos R.J., Schaedler R.W. The effect of diet on the fecal bacterial flora of mice and on their resistance to infection. Journal of Experimental Medicine 1962, 115:1161-1172.
31. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
32. Duggal P., Guo X., Haque R., Peterson K.M., Ricklefs S., Mondal D., et al. A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children. Journal of Clinical Investigation 2011, 121:1191-1198.
33. Duncan S.H., Lobley G.E., Holtrop G., Ince J., Johnstone A.M., Louis P., et al. Human colonic microbiota associated with diet, obesity and weight loss. International Journal of Obesity (London) 2008, 32:1720-1724.
34. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
35. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
36. Falkow S. Molecular Koch's postulates applied to bacterial pathogenicity-a personal recollection 15 years later. Nature Reviews Microbiology 2004, 2:67-72.
37. Finucane M.M., Stevens G.A., Cowan M.J., Danaei G., Lin J.K., Paciorek C.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
38. Fleissner C.K., Huebel N., Abd El-Bary M.M., Loh G., Klaus S., Blaut M. Absence of intestinal microbiota does not protect mice from diet-induced obesity. British Journal of Nutrition 2010, 104:919-929.
39. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
40. Gaboriau-Routhiau V., Rakotobe S., Lecuyer E., Mulder I., Lan A., Bridonneau C., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31:677-689.
41. Goldfine A.B., Fonseca V., Jablonski K.A., Pyle L., Staten M.A., Shoelson S.E. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Annals of Internal Medicine 2010, 152:346-357.
42. Goodman A.L., Kallstrom G., Faith J.J., Reyes A., Moore A., Dantas G., et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:6252-6257.
43. Goossens V.J., deJager S.A., Grauls G.E., Gielen M., Vlietinck R.F., Derom C.A., et al. Lack of evidence for the role of human adenovirus-36 in obesity in a European cohort. Obesity (Silver Spring) 2011, 19:220-221.
44. Greenberg D.E., Marshall-Batty K.R., Brinster L.R., Zarember K.A., Shaw P.A., Mellbye B.L., et al. Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex. Journal of Infectious Diseases 2010, 201:1822-1830.
45. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annual Review of Immunology 2011, 29:415-445.
46. Grinspoon S., Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. New England Journal of Medicine 2005, 352:48-62.
47. Guo X., Roberts M.R., Becker S.M., Podd B., Zhang Y., Chua S.C., et al. Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica. Mucosal Immunology 2011, 4:294-303.
48. Harper D.R., Enright M.C. Bacteriophages for the treatment of Pseudomonas aeruginosa infections. Journal of Applied Microbiology 2011, 111:1-7.
49. Henao-Mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
50. Hildebrandt M.A., Hoffmann C., Sherrill-Mix S.A., Keilbaugh S.A., Hamady M., Chen Y.Y., et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009, 137:1716-1724. (e1711-e1712).
51. Holmes E., Li J.V., Athanasiou T., Ashrafian H., Nicholson J.K. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends in Microbiology 2011, 19:349-359.
52. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
53. Hutchinson M.R., Zhang Y., Shridhar M., Evans J.H., Buchanan M.M., Zhao T.X., et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain, Behavior, and Immunity 2010, 24:83-95.
54. Ioannidis J.P. Genetic associations: false or true?. Trends in Molecular Medicine 2003, 9:135-138.
55. Ioannidis J.P. Non-replication and inconsistency in the genome-wide association setting. Human Heredity 2007, 64:203-213.
56. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
57. Ivanov I.I., Littman D.R. Segmented filamentous bacteria take the stage. Mucosal Immunology 2010, 3:209-212.
58. Ivanov I.I., Littman D.R. Modulation of immune homeostasis by commensal bacteria. Current Opinion in Microbiology 2011, 14:106-114.
59. Johannsen L., Rosenthal R.S., Martin S.A., Cady A.B., Obal F., Guinand M., et al. Somnogenic activity of O-acetylated and dimeric muramyl peptides. Infection and Immunity 1989, 57:2726-2732.
60. Jumpertz R., Le D.S., Turnbaugh P.J., Trinidad C., Bogardus C., Gordon J.I., et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. American Journal of Clinical Nutrition 2011, 94:58-65.
61. Kalliomaki M., Collado M.C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. American Journal of Clinical Nutrition 2008, 87:534-538.
62. Kamada N., Kim Y.G., Sham H.P., Vallance B.A., Puente J.L., Martens E.C., et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012, 336:1325-1329.
63. Kanzler R. Bakteriophagen und Bakterien im Duodenum beim Gesunden und Kranken. Journal of Molecular Medicine 1932, 11:3.
64. Kowalski T.J., Liu S.M., Leibel R.L., Chua S.C. Transgenic complementation of leptin-receptor deficiencyI. Rescue of the obesity/diabetes phenotype of LEPR-null mice expressing a LEPR-B transgene. Diabetes 2001, 50:425-435.
65. Kriegel M.A., Sefik E., Hill J.A., Wu H.J., Benoist C., Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:11548-11553.
66. Kuczynski J., Costello E.K., Nemergut D.R., Zaneveld J., Lauber C.L., Knights D., et al. Direct sequencing of the human microbiome readily reveals community differences. Genome Biology 2010, 11:210.
67. Kuczynski J., Lauber C.L., Walters W.A., Parfrey L.W., Clemente J.C., Gevers D., et al. Experimental and analytical tools for studying the human microbiome. Nature Reviews Genetics 2012, 13:47-58.
68. Larsen C.M., Faulenbach M., Vaag A., Volund A., Ehses J.A., Seifert B., et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. New England Journal of Medicine 2007, 356:1517-1526.
69. le Roux C.W., Bloom S.R. Peptide YY, appetite and food intake. Proceedings of the Nutrition Society 2005, 64:213-216.
70. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(1):4615-4622.
71. Letran S.E., Lee S.J., Atif S.M., Flores-Langarica A., Uematsu S., Akira S., et al. TLR5-deficient mice lack basal inflammatory and metabolic defects but exhibit impaired CD4 T cell responses to a flagellated pathogen. Journal of Immunology 2011, 186:5406-5412.
72. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:11070-11075.
73. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
74. Li J.V., Ashrafian H., Bueter M., Kinross J., Sands C., le Roux C.W., et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 2011, 60:1214-1223.
75. Lumeng C.N., Maillard I., Saltiel A.R. T-ing up inflammation in fat. Nature Medicine 2009, 15:846-847.
76. Macpherson A.J., Hunziker L., McCoy K., Lamarre A. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes and Infection 2001, 3:1021-1035.
77. Macpherson A.J., Martinic M.M., Harris N. The functions of mucosal T cells in containing the indigenous commensal flora of the intestine. Cellular and Molecular Life Sciences 2002, 59:2088-2096.
78. Manolios N., Geczy C.L., Schrieber L. High endothelial venule morphology and function are inducible in germ-free mice: a possible role for interferon-gamma. Cellular Immunology 1988, 117:136-151.
79. Marchiando A.M., Shen L., Graham W.V., Weber C.R., Schwarz B.T., Austin J.R., et al. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. Journal of Cell Biology 2010, 189:111-126.
80. Mariat D., Firmesse O., Levenez F., Guimaraes V., Sokol H., Dore J., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiology 2009, 9:123.
81. Maslowski K.M., Mackay C.R. Diet, gut microbiota and immune responses. Nature Immunology 2011, 12:5-9.
82. Mazmanian S.K. Gut immune balance is as easy as S-F-B. Immunity 2009, 31:536-538.
83. McAllister E.J., Dhurandhar N.V., Keith S.W., Aronne L.J., Barger J., Baskin M., et al. Ten putative contributors to the obesity epidemic. Critical Reviews in Food Science and Nutrition 2009, 49:868-913.
84. McNulty N.P., Yatsunenko T., Hsiao A., Faith J.J., Muegge B.D., Goodman A.L., et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Science Translational Medicine 2011, 3:106ra106.
85. Melnikova I., Wages D. Anti-obesity therapies. Nature Reviews Drug Discovery 2006, 5:369-370.
86. Metchnikoff E., Mitchell P.C. The prolongation of life: optimistic studies 1908, G.P. Putnam's Sons, New York & London.
87. Minot S., Sinha R., Chen J., Li H., Keilbaugh S.A., Wu G.D., et al. The human gut virome: inter-individual variation and dynamic response to diet. Genome Research 2011, 21:1616-1625.
88. Mitra A.K., Clarke K. Viral obesity: fact or fiction?. Obesity Reviews 2010, 11:289-296.
89. Mozaffarian D., Hao T., Rimm E.B., Willett W.C., Hu F.B. Changes in diet and lifestyle and long-term weight gain in women and men. New England Journal of Medicine 2011, 364:2392-2404.
90. Muccioli G.G., Naslain D., Backhed F., Reigstad C.S., Lambert D.M., Delzenne N.M., et al. The endocannabinoid system links gut microbiota to adipogenesis. Molecular Systems Biology 2010, 6:392.
91. Muramatsu T., Nakajima S., Okumura J. Modification of energy metabolism by the presence of the gut microflora in the chicken. British Journal of Nutrition 1994, 71:709-717.
92. Murphy E.F., Cotter P.D., Healy S., Marques T.M., O'Sullivan O., Fouhy F., et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010, 59:1635-1642.
93. Nadal I., Santacruz A., Marcos A., Warnberg J., Garagorri M., Moreno L.A., et al. Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents. International Journal of Obesity (London) 2009, 33:758-767.
94. Neyrinck A.M., Possemiers S., Druart C., Van de Wiele T., De Backer F., Cani P.D., et al. Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One 2011, 6(e20944).
95. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annual Review of Physiology 2010, 72:219-246.
96. Parfrey L.W., Walters W.A., Knight R. Microbial eukaryotes in the human microbiome: ecology, evolution, and future directions. Frontiers in Microbiology 2011, 2:153.
97. Pasarica M., Shin A.C., Yu M., Ou Yang H.M., Rathod M., Jen K.L., et al. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring) 2006, 14:1905-1913.
98. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M.B., Overvad K., et al. General and abdominal adiposity and risk of death in Europe. New England Journal of Medicine 2008, 359:2105-2120.
99. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics 2006, 38:904-909.
100. Proctor L.M. The Human Microbiome Project in 2011 and beyond. Cell Host and Microbe 2011, 10:287-291.
101. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
102. Ramachandrappa S., Farooqi I.S. Genetic approaches to understanding human obesity. Journal of Clinical Investigation 2011, 121:2080-2086.
103. Rawls J.F., Samuel B.S., Gordon J.I. Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:4596-4601.
104. Rea M.C., Dobson A., O'Sullivan O., Crispie F., Fouhy F., Cotter P.D., et al. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(1):4639-4644.
105. Reinhardt C., Bergentall M., Greiner T.U., Schaffner F., Ostergren-Lunden G., Petersen L.C., et al. Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature 2012, 483:627-631.
106. Renehan A.G., Soerjomataram I., Leitzmann M.F. Interpreting the epidemiological evidence linking obesity and cancer: a framework for population-attributable risk estimations in Europe. European Journal of Cancer 2010, 46:2581-2592.
107. Reyes A., Haynes M., Hanson N., Angly F.E., Heath A.C., Rohwer F., et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 2010, 466:334-338.
108. Sabate J.M., Jouet P., Harnois F., Mechler C., Msika S., Grossin M., et al. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obesity Surgery 2008, 18:371-377.
109. Samuel B.S., Gordon J.I. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:10011-10016.
110. Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., Manchester J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:16767-16772.
111. Sandoval D.A., Seeley R.J. Medicine. The microbes made me eat it. Science 2010, 328:179-180.
112. Santacruz A., Marcos A., Warnberg J., Marti A., Martin-Matillas M., Campoy C., et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring) 2009, 17:1906-1915.
113. Schaedler R.W., Dubos R.J. The fecal flora of various strains of mice. Its bearing on their susceptibility to endotoxin. Journal of Experimental Medicine 1962, 115:1149-1160.
114. Schwiertz A., Taras D., Schafer K., Beijer S., Bos N.A., Donus C., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010, 18:190-195.
115. Serino M., Luche E., Gres S., Baylac A., Berge M., Cenac C., et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 2012, 61:543-553.
116. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigation 2006, 116:3015-3025.
117. Shin S.C., Kim S.H., You H., Kim B., Kim A.C., Lee K.A., et al. Drosophila microbiome modulates host developmental and metabolic homeostasis via insulin signaling. Science 2011, 334:670-674.
118. Stappenbeck T.S., Hooper L.V., Gordon J.I. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:15451-15455.
119. Stienstra R., van Diepen J.A., Tack C.J., Zaki M.H., van de Veerdonk F.L., Perera D., et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:15324-15329.
120. Topping D.L., Clifton P.M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiological Reviews 2001, 81:1031-1064.
121. Turnbaugh P.J., Backhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host and Microbe 2008, 3:213-223.
122. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
123. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
124. Turnbaugh P.J., Ridaura V.K., Faith J.J., Rey F.E., Knight R., Gordon J.I. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Science Translational Medicine 2009, 1:6ra14.
125. Ubeda C., Taur Y., Jenq R.R., Equinda M.J., Son T., Samstein M., et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. Journal of Clinical Investigation 2010, 120:4332-4341.
126. Van Gaal L.F., Mertens I.L., De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444:875-880.
127. Vijay-Kumar M., Aitken J.D., Carvalho F.A., Cullender T.C., Mwangi S., Srinivasan S., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010, 328:228-231.
128. Vijay-Kumar M., Sanders C.J., Taylor R.T., Kumar A., Aitken J.D., Sitaraman S.V., et al. Deletion of TLR5 results in spontaneous colitis in mice. Journal of Clinical Investigation 2007, 117:3909-3921.
129. Virgin H.W., Todd J.A. Metagenomics and personalized medicine. Cell 2011, 147:44-56.
130. von Bernuth H., Picard C., Jin Z., Pankla R., Xiao H., Ku C.L., et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008, 321:691-696.
131. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. Journal of Clinical Investigation 2006, 116:115-124.
132. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003, 112:1796-1808.
133. Wing R.R., Phelan S. Long-term weight loss maintenance. American Journal of Clinical Nutrition 2005, 82:222S-225S.
134. Wu G.D., Chen J., Hoffmann C., Bittinger K., Chen Y.Y., Keilbaugh S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108.
135. Wu H.J., Ivanov, Darce J., Hattori K., Shima T., Umesaki Y., et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
136. Xiong Y., Miyamoto N., Shibata K., Valasek M.A., Motoike T., Kedzierski R.M., et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:1045-1050.
137. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
138. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., et al. Human gut microbiota in obesity and after gastric bypass. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:2365-2370.
139. Zuniga L.A., Shen W.J., Joyce-Shaikh B., Pyatnova E.A., Richards A.G., Thom C., et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. Journal of Immunology 2010, 185:6947-6959.